Loretta M. Byrne

Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer

Laine J. Murphey, Myles K. Williams, Stephanie Sanchez et al. · Analytical Biochemistry · 2004 · 169 citations

Healthy Humans, Biochemistry, Medicine +11

Interactive Hemodynamic Effects of Dipeptidyl Peptidase-IV Inhibition and Angiotensin-Converting Enzyme Inhibition in Humans

Annis Marney, Siri Kunchakarra, Loretta M. Byrne et al. · Hypertension · 2010 · 151 citations · Full text

Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome

Katie Ayers, Loretta M. Byrne, Anthony DeMatteo et al. · Hypertension · 2012 · 81 citations · Full text

Heart Failure, Nitric Oxide, Cardiovascular Pharmacology +19

Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned

Daniel F. Hanley, Gordon R. Bernard, Consuelo H. Wilkins et al. · Journal of Clinical and Translational Science · 2023 · 44 citations · Full text

New Technologies, Clinical Specialties, Population Health Sciences +21

The Recruitment Innovation Center: Developing novel, person-centered strategies for clinical trial recruitment and retention

Consuelo H. Wilkins, Terri Edwards, Mary Stroud et al. · Journal of Clinical and Translational Science · 2021 · 33 citations · Full text

Patient Selection, Clinical Endpoint, Trial Innovation Network +20